AB68,1537,25 21(6) Ethical standards. The commissioner shall promulgate a rule that
22contains ethical standards for pharmaceutical representatives and shall publish the
23ethical standards on the commissioner's Internet site. In addition to the ethical
24standards contained in the rule, a pharmaceutical representative may not do any of
25the following:
AB68,1538,3
1(a) Engage in deceptive or misleading marketing of a pharmaceutical,
2including the knowing concealment, suppression, omission, misleading
3representation, or misstatement of a material fact.
AB68,1538,84 (b) Use a title or designation that could reasonably lead a licensed health care
5professional, or an employee or representative of a licensed health care professional,
6to believe that the pharmaceutical representative is licensed to practice medicine,
7nursing, dentistry, optometry, pharmacy, or other similar health occupation in this
8state unless the pharmaceutical representative holds a license to practice.
AB68,1538,99 (c) Attend a patient examination without the patient's consent.
AB68,1538,12 10(7) Enforcement. (a) Any individual violating this section shall be fined not
11less than $1,000 nor more than $3,000 for each offense. Each day the violation
12continues shall constitute a separate offense.
AB68,1538,1813 (b) The commissioner may suspend or revoke the license of a pharmaceutical
14representative who violates this section. A suspended or revoked license may not be
15reinstated until all violations related to the suspension or revocation have been
16remedied and all assessed penalties and fees have been paid. An individual whose
17pharmaceutical representative license is revoked for any cause may not be issued a
18license under sub. (2) (a) until at least 2 years after the date of revocation.
AB68,1538,2219 (c) A health care professional who meets with a pharmaceutical representative
20who does not display his or her license or share the information required under sub.
21(5) may report the pharmaceutical representative to the commissioner for further
22action.
AB68,1538,23 23(8) Rules. The commissioner may promulgate rules to implement this section.
AB68,2958 24Section 2958. 632.864 of the statutes is created to read:
AB68,1539,2
1632.864 Pharmacy services administrative organizations. (1)
2Definitions. In this section:
AB68,1539,33 (a) “Administrative service” means any of the following:
AB68,1539,44 1. Assisting with claims.
AB68,1539,55 2. Assisting with audits.
AB68,1539,66 3. Providing centralized payment.
AB68,1539,77 4. Performing certification in a specialized care program.
AB68,1539,88 5. Providing compliance support.
AB68,1539,99 6. Setting flat fees for generic drugs.
AB68,1539,1010 7. Assisting with store layout.
AB68,1539,1111 8. Managing inventory.
AB68,1539,1212 9. Providing marketing support.
AB68,1539,1313 10. Providing management and analysis of payment and drug dispensing data.
AB68,1539,1414 11. Providing resources for retail cash cards.
AB68,1539,1715 (b) “Independent pharmacy" means a pharmacy operating in this state that is
16licensed under s. 450.06 or 450.065 and is under common ownership with no more
17than 2 other pharmacies.
AB68,1539,1818 (c) “Pharmacy benefit manager” has the meaning given in s. 632.865 (1) (c).
AB68,1539,2019 (d) “Pharmacy services administrative organization” means an entity
20operating in this state that does all of the following:
AB68,1539,2221 1. Contracts with an independent pharmacy to conduct business on the
22pharmacy's behalf with a 3rd-party payer.
AB68,1539,2523 2. Provides at least one administrative service to an independent pharmacy
24and negotiates and enters into a contract with a 3rd-party payer or pharmacy benefit
25manager on behalf of the pharmacy.
AB68,1540,3
1(e) “Third-party payer” means an entity, including a plan sponsor, health
2maintenance organization, or insurer, operating in this state that pays or insures
3health, medical, or prescription drug expenses on behalf of beneficiaries.
AB68,1540,8 4(2) Licensure. (a) A person may not operate as a pharmacy services
5administrative organization in this state without a pharmacy services
6administrative organization license. In order to obtain a license, a person shall apply
7to the commissioner in the form and manner prescribed by the commissioner. The
8application shall include all of the following:
AB68,1540,109 1. The name, address, telephone number, and federal employer identification
10number of the applicant.
AB68,1540,1211 2. The name, business address, and telephone number of a contact person for
12the applicant.
AB68,1540,1313 3. The fee under s. 601.31 (1) (nw).
AB68,1540,1414 4. Evidence of financial responsibility of at least $1,000,000.
AB68,1540,1515 5. Any other information required by the commissioner.
AB68,1540,1716 (b) The term of a license issued under par. (a) shall be 2 years from the date of
17issuance.
AB68,1540,21 18(3) Disclosure to the commissioner. (a) A pharmacy services administrative
19organization shall disclose to the commissioner the extent of any ownership or
20control of the pharmacy services administrative organization by an entity that does
21any of the following:
AB68,1540,2222 1. Provides pharmacy services.
AB68,1540,2323 2. Provides prescription drug or device services.
AB68,1540,2524 3. Manufactures, sells, or distributes prescription drugs, biologicals, or medical
25devices.
AB68,1541,3
1(b) A pharmacy services administrative organization shall notify the
2commissioner in writing within 5 days of any material change in its ownership or
3control relating to an entity described in par. (a).
AB68,1541,4 4(4) Rules. The commissioner may promulgate rules to implement this section.
AB68,2959 5Section 2959 . 632.865 (1) (a) of the statutes is renumbered 632.865 (1) (aw).
AB68,2960 6Section 2960 . 632.865 (1) (ae) and (ak) of the statutes are created to read:
AB68,1541,77 632.865 (1) (ae) “Health benefit plan” has the meaning given in s. 632.745 (11).
AB68,1541,88 (ak) “Health care provider” has the meaning given in s. 146.81 (1).
AB68,2961 9Section 2961 . 632.865 (1) (c) of the statutes is renumbered 632.865 (1) (c)
10(intro.) and amended to read:
AB68,1541,1311 632.865 (1) (c) (intro.) “Pharmacy benefit manager" means an entity doing
12business in this state that contracts to administer or manage prescription drug
13benefits on behalf of any of the following:
AB68,1541,14 141. An insurer or other.
AB68,1541,16 153. Another entity that provides prescription drug benefits to residents of this
16state.
AB68,2962 17Section 2962 . 632.865 (1) (c) 2. of the statutes is created to read:
AB68,1541,1818 632.865 (1) (c) 2. A cooperative, as defined in s. 185.01 (2).
AB68,2963 19Section 2963 . 632.865 (1) (dm) of the statutes is created to read:
AB68,1541,2020 632.865 (1) (dm) “Prescription drug" has the meaning given in s. 450.01 (20).
AB68,2964 21Section 2964. 632.865 (2m) of the statutes is created to read:
AB68,1541,2522 632.865 (2m) Fiduciary duty and disclosures to health benefit plan
23sponsors
. (a) A pharmacy benefit manager owes a fiduciary duty to the health
24benefit plan sponsor to act according to the health benefit plan sponsor's instructions
25and in the best interests of the health benefit plan sponsor.
AB68,1542,3
1(b) A pharmacy benefit manager shall annually provide, no later than the date
2and using the method prescribed by the commissioner by rule, the health benefit plan
3sponsor all of the following information from the previous calendar year:
AB68,1542,54 1. The indirect profit received by the pharmacy benefit manager from owning
5any interest in a pharmacy or service provider.
AB68,1542,76 2. Any payment made by the pharmacy benefit manager to a consultant or
7broker who works on behalf of the health benefit plan sponsor.
AB68,1542,118 3. From the amounts received from all drug manufacturers, the amounts
9retained by the pharmacy benefit manager, and not passed through to the health
10benefit plan sponsor, that are related to the health benefit plan sponsor's claims or
11bona fide service fees.
AB68,1542,1612 4. The amounts, including pharmacy access and audit recovery fees, received
13from all pharmacies that are in the pharmacy benefit manager's network or have a
14contract to be in the network and, from these amounts, the amount retained by the
15pharmacy benefit manager and not passed through to the health benefit plan
16sponsor.
AB68,2965 17Section 2965 . 632.865 (3) to (7) of the statutes are created to read:
AB68,1542,2018 632.865 (3) License required. No person may perform any activities of a
19pharmacy benefit manager without being licensed by the commissioner as an
20administrator or pharmacy benefit manager under s. 633.14.
AB68,1543,2 21(4) Accreditation for network participation. A pharmacy benefit manager or
22a representative of a pharmacy benefit manager shall provide to a pharmacy, within
2330 days of receipt of a written request from the pharmacy, a written notice of any
24certification or accreditation requirements used by the pharmacy benefit manager
25or its representative as a determinant of network participation. A pharmacy benefit

1manager or a representative of a pharmacy benefit manager may change its
2accreditation requirements no more frequently than once every 12 months.
AB68,1543,5 3(5) Retroactive claim reduction. Unless required otherwise by federal law,
4a pharmacy benefit manager may not retroactively deny or reduce a pharmacist's or
5pharmacy's claim after adjudication of the claim unless any of the following is true:
AB68,1543,66 (a) The original claim was submitted fraudulently.
AB68,1543,97 (b) The payment for the original claim was incorrect. Recovery for an incorrect
8payment under this paragraph is limited to the amount that exceeds the allowable
9claim.
AB68,1543,1010 (c) The pharmacy services were not rendered by the pharmacist or pharmacy.
AB68,1543,1211 (d) In making the claim or performing the service that is the basis for the claim,
12the pharmacist or pharmacy violated state or federal law.
AB68,1543,1413 (e) The reduction is permitted in a contract between a pharmacy and a
14pharmacy benefit manager and is related to a quality program.
AB68,1543,15 15(6) Audits of pharmacies or pharmacists. (a) Definitions. In this subsection:
AB68,1543,1816 1. “Audit” means a review of the accounts and records of a pharmacy or
17pharmacist by or on behalf of an entity that finances or reimburses the cost of health
18care services or prescription drugs.
AB68,1543,2219 2. “Entity” means a defined network plan, as defined in s. 609.01 (1b), insurer,
20self-insured health plan, or pharmacy benefit manager or a person acting on behalf
21of a defined network plan, insurer, self-insured health plan, or pharmacy benefit
22manager.
AB68,1543,2323 3. “Self-insured health plan” has the meaning given in s. 632.85 (1) (c).
AB68,1543,2524 (b) Procedures. An entity conducting an on-site or desk audit of pharmacist
25or pharmacy records shall do all of the following:
AB68,1544,3
11. If the audit is an audit on the premises of the pharmacist or pharmacy, notify
2the pharmacist or pharmacy in writing of the audit at least 2 weeks before conducting
3the audit.
AB68,1544,64 2. Refrain from auditing a pharmacist or pharmacy within the first 5 business
5days of a month unless the pharmacist or pharmacy consents to an audit during that
6time.
AB68,1544,87 3. If the audit involves clinical or professional judgment, conduct the audit by
8or in consultation with a pharmacist licensed in any state.
AB68,1544,109 4. Limit the audit review to no more than 250 separate prescriptions. For
10purposes of this subdivision, a refill of a prescription is not a separate prescription.
AB68,1544,1211 5. Limit the audit review to claims submitted no more than 2 years before the
12date of the audit, unless required otherwise by state or federal law.
AB68,1544,1813 6. Allow the pharmacist or pharmacy to use authentic and verifiable records
14of a hospital, physician, or other health care provider to validate the pharmacist's or
15pharmacy's records relating to delivery of a prescription drug and use any valid
16prescription that complies with requirements of the pharmacy examining board to
17validate claims in connection with a prescription, refill of a prescription, or change
18in prescription.
AB68,1544,2119 7. Allow the pharmacy or pharmacist to document the delivery of a prescription
20drug or pharmacist services to an enrollee under a health benefit plan using either
21paper or electronic signature logs.
AB68,1544,2422 8. Before leaving the pharmacy after concluding the on-site portion of an audit,
23provide to the representative of the pharmacy or the pharmacist a complete list of
24the pharmacy records reviewed.
AB68,1545,2
1(c) Results of audit. An entity that has conducted an audit of a pharmacist or
2pharmacy shall do all of the following:
AB68,1545,103 1. Deliver to the pharmacist or pharmacy a preliminary report of the audit
4within 60 days after the date the auditor departs from an on-site audit or the
5pharmacy or pharmacist submits paperwork for a desk audit. A preliminary report
6under this subdivision shall include claim-level information for any discrepancy
7reported, the estimated total amount of claims subject to recovery, and contact
8information for the entity or person that completed the audit so the pharmacist or
9pharmacy subject to the audit may review audit results, procedures, and
10discrepancies.
AB68,1545,1311 2. Allow a pharmacist or pharmacy that is the subject of an audit to provide
12documentation to address any discrepancy found in the audit within 30 days after
13the date the pharmacist or pharmacy receives the preliminary report.
AB68,1545,1914 3. Deliver to the pharmacist or pharmacy a final audit report, which may be
15delivered electronically, within 90 days of the date the pharmacist or pharmacy
16receives the preliminary report or the date of the final appeal of the audit, whichever
17is later. The final audit report under this subdivision shall include any response
18provided to the auditor by the pharmacy or pharmacist and consider and address the
19pharmacy's or pharmacist's response.
AB68,1545,2220 4. Refrain from assessing a recoupment or other penalty on a pharmacist or
21pharmacy until the appeal process is exhausted and the final report under subd. 3.
22is delivered to the pharmacist or pharmacy.
AB68,1545,2423 5. Refrain from accruing or charging interest between the time the notice of the
24audit is given under par. (b) 1. and the final report under subd. 3. has been delivered.
AB68,1545,2525 6. Exclude dispensing fees from calculations of overpayments.
Loading...
Loading...